BridgeMD
New treatment option for Patellofemoral Dislocation
Official title Biologic Augment of the Medial Patellofemoral Ligament Following Primary Lateral Patellofemoral Dislocation (BioPPD)
ClinicalTrials.gov ID: NCT06169800
What this study is testing
- What it's testing
- This study aims to determine the ability of medial patellofemoral ligament (MPFL) repair augmented with Biobrace® to decrease the re-dislocation rate after a primary patellofemoral dislocation. First-time patellofemoral dislocation is a significant problem, and the ramifications of recurrence for patients are substantial.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 30
You may be able to join if
- Age 13 - 30 years
- First-time lateral patellofemoral dislocation in the previous 7 days
- Closed or closing growth plates (confirmed on knee x-rays with no change required for surgical technique)
You likely can't join if
- History of previous patellofemoral dislocation on the index knee
- An osteochondral fracture of the patellofemoral joint that requires surgical repair
- Unable to complete computer-based outcome questionnaires
- Pregnant at the time of surgery
The study team makes the final eligibility decision.
Where it's taking place
- Canmore, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 30 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Canmore, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.